In addition, GBMs that are primarily resistant to TMZ tend to have an immunosuppressive tumor microenvironment stimulated by NHE1 protein overexpression and inhibition of the NHE1-enhanced cytotoxic effects of TMZ, leading to enhanced tumor growth (27). Here, SLC9A1 is linked to neoplasm.